Details for Patent: 10,392,406

Which drugs does patent 10,392,406 protect, and when does it expire?

Patent 10,392,406 protects XOFLUZA and is included in two NDAs.

This patent has seventy-six patent family members in thirty-seven countries.

Summary for Patent: 10,392,406

Title:	Substituted polycyclic pyridone derivatives and prodrugs thereof
Abstract:	The present invention provides the following compounds having anti-viral activity. ##STR00001## A.sup.1 is CR.sup.1AR.sup.1B, S or O; A.sup.2 is CR.sup.2AR.sup.2B, S or O; A.sup.3 is CR.sup.3AR.sup.3B, S or O; A.sup.4 is CR.sup.4AR.sup.4B, S or O; the number of hetero atoms among atoms constituting the ring which consists of A.sup.1, A.sup.2, A.sup.3, A.sup.4, nitrogen atom adjacent to A.sup.1 and carbon atom adjacent to A.sup.1, is 1 or 2; R.sup.1A and R.sup.1B are each independently hydrogen, halogen, alkyl, or the like; R.sup.2A and R.sup.2B are each independently hydrogen, halogen, alkyl, or the like; R.sup.3A and R.sup.3B are each independently hydrogen, halogen, alkyl, or the like; R.sup.4A and R.sup.4B are each independently hydrogen, halogen, alkyl, or the like; R.sup.3A and R.sup.3B may be taken together to form non-aromatic carbocycle or non-aromatic heterocycle; X is CH.sub.2, S or O; R.sup.1 is each independently halogen, hydroxy, or the like; m is any integer of 0 to 2; and n is any integer of 1 to 2.
Inventor(s):	Kawai; Makoto (Osaka, JP)
Assignee:	SHIONOGI & CO., LTD. (Osaka, JP)
Application Number:	15/569,191
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 10,392,406

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Genentech Inc	XOFLUZA	baloxavir marboxil	FOR SUSPENSION;ORAL	214410-001	Nov 23, 2020		RX	Yes	Yes				Y
Genentech Inc	XOFLUZA	baloxavir marboxil	TABLET;ORAL	210854-001	Oct 24, 2018		DISCN	Yes	No				Y
Genentech Inc	XOFLUZA	baloxavir marboxil	TABLET;ORAL	210854-002	Oct 24, 2018		RX	Yes	No				Y
Genentech Inc	XOFLUZA	baloxavir marboxil	TABLET;ORAL	210854-003	Mar 18, 2021		RX	Yes	Yes				Y

Foreign Priority and PCT Information for Patent: 10,392,406

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2015-090909	Apr 28, 2015
Japan	2015-236844	Dec 3, 2015

PCT Information
PCT Filed	April 27, 2016	PCT Application Number:	PCT/JP2016/063139
PCT Publication Date:	March 11, 2016	PCT Publication Number:	WO2016/175224

International Family Members for US Patent 10,392,406

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	3428170		LUC00198	Luxembourg
European Patent Office	3428170		C20210003 00390	Estonia
European Patent Office	4219508		122024000036	Germany
Argentina	104428
Australia	2016256125